Clinical Research in Gynaecological Cancers and Carcinoma of Unknown Primary

PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors

M Tang, RL O'Connell, F Amant, P Beale, O McNally, KM Sjoquist, P Grant, A Davis, P Sykes, L Mileshkin, T Moujaber, CJ Kennedy, A deFazio, K Tan, Y Antill, J Goh, T Bonaventura, J Scurry, M Friedlander

2019-09-01

Objective: Treatment options are limited for patients with recurrent/metastatic low-grade ovarian cancers (LGOCs) and serous borde..